ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome

Trial ID or NCT#

NCT02848274

Status

recruiting iconRECRUITING

Purpose

The purpose of the study is to develop a prognostic index model for the rare disease of mycosis fungoides and sezary syndrome. This will be done by collecting standardized clinical data at various institutions. The investigators hope this will enable the identification of low- and high-risk groups for survival in order to improve patient care and outcome.

Official Title

Prospective Multicenter International Observational Study for Determination of a Cutaneous Lymphoma International Prognostic Index Model and Impact of Major Therapies in Patients With Advanced Mycosis Fungoides and Sézary Syndrome

Eligibility Criteria

Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. * Diagnosis of advanced stage MF or SS (Stages IIB - IVB) within 6 months of presentation to the participating center* Patients that are expected to have care administered at the participating center or jointly with referring physician(s) where follow-up data would be available
    1. Exclusion Criteria
  2. * Patients diagnosed with early stage MF/SS (Stages IA-IIA) before progressing to advanced stage* Patients diagnosed with advanced MF/SS more than 6 months prior to initial presentation to the participating center* Exclude one-time consultation type of new patients.
Exclusion Criteria:
  1. * Patients diagnosed with early stage MF/SS (Stages IA-IIA) before progressing to advanced stage* Patients diagnosed with advanced MF/SS more than 6 months prior to initial presentation to the participating center* Exclude one-time consultation type of new patients.
View All Criteria
Show Less

Investigator(s)

Youn H Kim, MD
Youn H Kim, MD
Dermatologic oncologist, Cutaneous oncology specialist, Dermatologist
The Joanne and Peter Haas, Jr., Professor for Cutaneous Lymphoma Research and Professor, by courtesy, of Medicine (Oncology)
Richard T Hoppe
Richard T Hoppe
Radiation oncologist
Henry S. Kaplan-Harry Lebeson Professor of Cancer Biology, Emeritus

Contact us to find out if this trial is right for you.

Contact

Tatiana Neal
650-709-7838

SEND MESSAGE

View on ClinicalTrials.gov